Holoclar for Limbal stem cell deficiency due to ocular burns
Quick answer: Holoclar is used for Limbal stem cell deficiency due to ocular burns as part of a advanced therapy medicinal product (ex vivo expanded autologous limbal stem cells) treatment regimen. Autologous corneal epithelial cells containing limbal stem cells that restore corneal epithelium after ocular burns The specific dosing for Limbal stem cell deficiency due to ocular burns is determined by your prescriber based on individual factors.
Why is Holoclar used for Limbal stem cell deficiency due to ocular burns?
Holoclar belongs to the Advanced therapy medicinal product (ex vivo expanded autologous limbal stem cells) class. Autologous corneal epithelial cells containing limbal stem cells that restore corneal epithelium after ocular burns This action makes it useful for treating or managing Limbal stem cell deficiency due to ocular burns in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Holoclar is the right choice for a specific patient depends on the type and severity of Limbal stem cell deficiency due to ocular burns, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Limbal stem cell deficiency due to ocular burns
Common adult dosing range: Single transplant of 79,000-316,000 cells/cm² applied to affected eye. The actual dose for Limbal stem cell deficiency due to ocular burns depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Holoclar medicine page.
What to expect
Holoclar treatment for Limbal stem cell deficiency due to ocular burns typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Limbal stem cell deficiency due to ocular burns
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Holoclar is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Advanced therapy medicinal product (ex vivo expanded autologous limbal stem cells) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Holoclar
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Holoclar full prescribing information · All Advanced therapy medicinal product (ex vivo expanded autologous limbal stem cells) alternatives
Frequently asked questions
How effective is Holoclar for Limbal stem cell deficiency due to ocular burns?
Effectiveness varies by individual response, dose, and severity. Holoclar is one of several treatment options for Limbal stem cell deficiency due to ocular burns, supported by clinical evidence within the advanced therapy medicinal product (ex vivo expanded autologous limbal stem cells) class. Discuss expected response with your prescriber.
How long do I need to take Holoclar for Limbal stem cell deficiency due to ocular burns?
Treatment duration depends on the nature of Limbal stem cell deficiency due to ocular burns — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Holoclar when used for Limbal stem cell deficiency due to ocular burns?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Holoclar for Limbal stem cell deficiency due to ocular burns?
Yes. Multiple medicines and non-drug options exist for Limbal stem cell deficiency due to ocular burns. Alternatives within the advanced therapy medicinal product (ex vivo expanded autologous limbal stem cells) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.